Subacute Thyroiditis and Graves’ Disease Possibly Associated with Sars-CoV-2 Infection: Presentation of Two Cases and Review of the Current Data

Abstract views: 80 / PDF downloads: 59




COVID-19, Graves’ disease, SARS-CoV-2, subacute thyroiditis, thyroid


The severe acute respiratory syndrome coronavirus 2 has been identified as the cause of a pandemic of respiratory illness in Wuhan, China. Coronavirus disease 2019 may cause mild disease with nonspecific signs and symptoms such as fever, cough, myalgia, and fatigue or severe pneumonia with respiratory failure and sepsis. It is not clear whether coronavirus disease 2019 has an effect on the thyroid gland. Evidence support that patients with coronavirus disease 2019 who are followed up in the intensive care unit may develop temporary thyroid dysfunction as non-thyroidal illness syndrome. Until now, 22 cases of subacute thyroiditis and 5 Graves’ diseases potentially related to severe acute respiratory syndrome coronavirus 2 infection have been presented in the literature. Herein, we present 2 cases with subacute thyroiditis and Graves’ diseases potentially related to severe acute respiratory syndrome coronavirus 2 infection in the context of the review of the literature. Physicians should be aware of the possible relationship between thyroid dysfunction and coronavirus disease 2019.


Metrics Loading ...


Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.

Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43(7):1027-1031.

Liu F, Long X, Zou W, et al. Highly ACE2 expression in pancreas may cause pancreas damage after SARS-CoV-2 infection. Available at: https ://me drx.i /look up/do i/10. 1101/ 2020. 02.28 .2002 9.181.

Samuels MH. Subacute, silent, and postpartum thyroiditis. Med Clin North Am. 2012;96(2):223-233.

Alfadda AA, Sallam RM, Elawad GE, Aldhukair H, Alyahya MM. Subacute thyroiditis: clinical presentation and long term outcome. Int J Endocrinol. 2014;2014:794943.

Erdem N, Erdogan M, Ozbek M, et al. Demographic and clinical features of patients with subacute thyroiditis: results of 169 patients from a single university center in Turkey. J Endocrinol Invest. 2007;30(7):546-550.

Fatourechi V, Aniszewski JP, Fatourechi GZ, Atkinson EJ, Jacobsen SJ. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study [study]. J Clin Endocrinol Metab. 2003;88(5):2100-2105.

Stasiak M, Tymoniuk B, Stasiak B, Lewiński A. The risk of recurrence of subacute thyroiditis is HLA-Dependent. Int J Mol Sci. 2019;20(5):1089.

Dimos G, Pappas G, Akritidis N. Subacute thyroiditis in the course of novel H1N1 influenza infection. Endocrine. 2010;37(3):440-441.

Desailloud R, Hober D. Virus and thyroiditis: an update. Virol J. 2009;6:5.

Ding Y, He L, Zhang Q, et al. Organ Distribution of severe acute respiratory syndrome (SARS) Associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203(2):622-630.

Wei L, Sun S, Xu CH, et al. Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol. 2007;38(1):95-102.

Yao XH, Li TY, He ZC, et al. Histopathological study of new coronavirus pneumonia (COVID-19) in three patients. Zhonghua Bing Li Xue Za Zhi. 2020;8(49 (5)):411-417.

Rotondi M, Coperchini F, Ricci G, et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2021;44(5):1085-1090.

Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F. Subacute thyroiditis after Sars-COV-2 infection. J Clin Endocrinol Metab. 2020;105(7):dgaa276.

Ippolito S, Dentali F, Tanda ML. SARS‑CoV2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. 2020;43(8):1171-1172.

Asfuroglu Kalkan E, Ates I. A case of subacute thyroiditis associated with Covid-19 infection. J Endocrinol Invest. 2020;43(8):1173-1174.

Ruggeri RM, Campennì A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones (Athens). 2021;20(1):219-221.

Brancatella A, Ricci D, Cappellani D, et al. Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series. J Clin Endocrinol Metab. 2020;105(10):dgaa537.

Mattar SAM, Koh SJQ, Rama Chandran S, Cherng BPZ. Subacute thyroiditis associated with COVID-19. BMJ Case Rep. 2020;13(8).

Khatri A, Charlap E, Kim A. Subacute thyroiditis from COVID-19 infection: A case report and review of literature. Eur Thyroid J. 2021;9(6):324-328.

Campos-Barrera E, Alvarez-Cisneros T, Davalos-Fuentes M. Subacute thyroiditis associated with COVID-19. Case Rep Endocrinol. 2020;2020:8891539.

Ruano R, Zorzano-Martinez M, Campos A, Rius F, Hernández M. Subacute thyroiditis might be a complication triggered by SARSCoV-2. Endocrinol Diabetes Nutr. 2020;13:S2530 -0164 (20)3 0206- 8.

Chong WH, Shkolnik B, Saha B, Beegle S. Subacute thyroiditis in the setting of coronavirus disease 2019. Am J Med Sci. 2021;361(3):400-402.

San Juan MDJ, Florencio MQV, Joven MH. Subacute thyroiditis in a patient with coronavirus disease 2019. AACE. Clin Case Rep. 2020; 23(6):e361-e364.

Álvarez Martín MC, Del Peso Gilsanz C, Hernández López A. Subacute de Quervain thyroiditis after SARS-CoV-2 infection. Endocrinol Diabetes Nutr. 2020;2:S2530 -0164 (20)3 0244- 5.

Chakraborty U, Ghosh S, Chandra A, Ray AK. Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity. BMJ Case Rep. 2020;13(12).

Sohrabpour S, Heidari F, Karimi E, Ansari R, Tajdini A, Heidari F. Subacute thyroiditis in COVID-19 patients. Eur Thyroid J. 2021;9(6):321-323.

Caron P. Thyroiditis and SARS-CoV-2 pandemic: a review. Endocrine. 2021;72(2):326-331.

Antonelli A, Ferrari SM, Ragusa F, et al. Graves’ disease: epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101387.

Valtonen VV, Ruutu P, Varis K, Ranki M, Malkamäki M, Mäkelä PH. Serological evidence for the role of bacterial infections in the pathogenesis of thyroid diseases. Acta Med Scand. 1986;219(1):105-111.

Shukla SK, Singh G, Ahmad S, Pant P. Infections, genetic and environmental Factors in pathogenesis of autoimmune thyroid diseases. Microb Pathog. 2018;116:279-288.

Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID-19. J Endocrinol Invest. 2020;43(10):1527-1528.

Jiménez-Blanco S, Pla-Peris B, Marazuela M. COVID-19: a cause of recurrent Graves’ hyperthyroidism? J Endocrinol Invest. 2021;44(2):387-388.

Pastor S, Molina Á Sr, De Celis E. Thyrotoxic crisis and COVID-19 infection: an extraordinary case and literature review. Cureus. 2020;12(11):e11305.

Chiovato L, Pinchera A. Stressful life events and Graves’ disease. Eur J Endocrinol. 1996;134(6):680-682.

Vita R, Lapa D, Trimarchi F, Benvenga S. Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves’ disease. Endocrine. 2015;48(1):254-263.

Topcu CB, Celik O, Tasan E. Effect of stressful life events on the initiation of Graves’ disease. Int J Psychiatry Clin Pract. 2012;16(4):307-311.

Agcaoglu O, Sezer A, Makay O, et al. Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for nonsurgical options. Update Surg. 2022;74(1):325-335.




How to Cite

Çelik, Özlem, & Anaforoğlu, İnan. (2022). Subacute Thyroiditis and Graves’ Disease Possibly Associated with Sars-CoV-2 Infection: Presentation of Two Cases and Review of the Current Data. European Journal of Therapeutics, 28(2), 158–162.



Review Articles